News: Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
08/15Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of Ctdna for Colorectal and Pancreatic Cancers
CI
08/15NOVO NORDISK : Receives a Buy rating from Barclays
MD
08/15NovAccess Global Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
CI
08/15Bellerophon Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15MyMD Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15ContraFect Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15MediPharm Labs to Seek M&A
CI
08/15Gilead Sciences, Inc. Announces Trodelvy® Significantly Improves Overall Survival in Pre-Treated HR+/Her2- Metastatic Breast Cancer Patients in the Tropics-02 Study
CI
08/15Sienna Senior Living Inc. Announces Dividend for the Month of August 2022, Payable on September 15, 2022
CI
08/15PharmaCyte Biotech, Inc. Announces Board Appointments
CI
08/15Anixa Biosciences Announces Treatment of First Patient in Its Ovarian Cancer Car-T Clinical Trial
CI
08/15TRANSCRIPT : Medicenna Therapeutics Corp., Q1 2023 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : SCYNEXIS, Inc., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : DarioHealth Corp., Q2 2022 Earnings Call, Aug 15, 2022
CI
Discover
08/15TRANSCRIPT : Alaunos Therapeutics, Inc., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : SNDL Inc., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : Atai Life Sciences N.V., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : MediPharm Labs Corp., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : Impel Pharmaceuticals Inc., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : TherapeuticsMD, Inc., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : Protalix BioTherapeutics, Inc., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : Gelesis Holdings, Inc., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15BAYER AG : Barclays remains its Buy rating
MD
08/15Serum Institue of India's Poonawalla expects Omicron-specific vaccine in 6 months -NDTV
RE
08/15SYNLAB : Barclays reaffirms its Buy rating
MD
08/15Palisade Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15First Wave BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Novavax seeks U.S. authorization for COVID vaccine booster
RE
08/15Town Health International Medical Group Limited Appoints Mr. Han Wenxin as an Independent Non-Executive Director with Effect from 15 August 2022
CI
08/15Kindstar Globalgene Technology, Inc. Announces Executive Changes
CI
08/15Talaris Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Accelerate Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Chartwell Retirement Residences Announces August 2022 Cash Distribution, Payable on September 15, 2022
CI
08/15Novavax seeks U.S. authorization for COVID vaccine booster
RE
08/15Adagio Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Pardes Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15CNS Pharmaceuticals, Inc. Provides A Clinical Update of Its Anti-Cancer Drug Candidates Currently in Development for the Treatment of Primary and Metastatic Brain and CNS Cancer
CI
08/15Outlook Therapeutics, Inc. Announces Appointment of Julia A. Haller as Board of Director
CI
08/15HiFiBiO Therapeutics Announces Clinical Trial Supply Agreement to Evaluate HFB200301 in Combination with Tislelizumab in Patients with DIS™ Selected Advanced Solid Tumors
CI
08/15Kovo HealthTech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Impel Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15La Jolla Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Cocrystal Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Aerovate Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Vaccinex, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15AIM ImmunoTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15TRANSCRIPT : Columbia Care Inc., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : Rockwell Medical, Inc., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : Gracell Biotechnologies Inc., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : Embecta Corp., Q3 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : Brainstorm Cell Therapeutics Inc., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : Gamida Cell Ltd., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15TRANSCRIPT : Viridian Therapeutics, Inc., Q2 2022 Earnings Call, Aug 15, 2022
CI
08/15Q32 Bio and Horizon Therapeutics plc Announces Collaboration in Autoimmune Diseases
CI
08/15TRANSCRIPT : Roivant Sciences Ltd., Q1 2023 Earnings Call, Aug 15, 2022
CI
08/15Agios Pharmaceuticals, Inc. Appoints Rahul Ballal and Cynthia Smith to Board of Directors
CI
08/15Amarin Corporation plc Announces New Research on the Effects of VASCEPA®/VAZKEPA at the European Society of Cardiology Congress
CI
08/15Novavax, Inc. Submits Application to the U.S. FDA for Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster in Adults Aged 18 and Older
CI
08/15The Recovery Team Launches Brainsway Deep TMS
CI
08/15Celsion Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Embecta Seeks Acquisitions
CI
08/15Vibhavadi Medical Center Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Saintmed Public Company Limited Announces Dividend for the Operating Period from 01 January 2022 to 30 June 2022, Payable on 14 September 2022
CI
08/15Galectin Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Discover
08/15Small Pharma Inc. Receives Approval for DMT-Assisted Psychotherapy and Ssri Drug Interaction Study
CI
08/15Nuvo Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Halozyme Therapeutics to Seek Acquisitions
CI
08/15Nuvo Pharmaceuticals Inc. Appoints Anthony Snow to the Board of Directors
CI
08/15Kovo HealthTech Corporation Provides Earnings Guidance for the Full Year 2022
CI
Prev.1  2  3   4  5  6  7  8  9  10Next